Categories AlphaGraphs, Earnings, Other Industries

Danaher Q3 profit rises 15%, beats estimates

Danaher Corp. (DHR) reported a 16% increase in earnings for the third quarter driven by core revenue growth, solid operating margin expansion, as well as mid-single-digit revenue growth in four of the five platforms. The top and bottom line exceeded analysts’ expectations.

Net income increased 16% to $663.7 million or $0.93 per share. Non-GAAP earnings grew 10% to $1.10 per share. Revenue rose 7.2% to $4.9 billion with non-GAAP core revenue growth of 6.5%.

Danaher third quarter 2018 Earnings Infographic
Danaher Q3 2018 Earnings Infographics

Looking ahead into the fourth quarter, Danaher expects earnings in the range of $1.04 to $1.07 per share and non-GAAP earnings of $1.25 to $1.28 per share.

For the full year 2018, the company lifted earnings guidance to the range of $3.72 to $3.75 per share from the prior range of $3.64 to $3.71 per share. Non-GAAP EPS outlook was raised to the range of $4.49 to $4.52 from the previous estimate of $4.43 to $4.50.

“We are very pleased with our performance in the third quarter, as the team maintained strong momentum and delivered outstanding results. Our recent performance is a testament to the team’s execution and drive for continuous improvement,” Chief Executive Thomas P. Joyce Jr. said.

Despite the positive results, shares of Danaher fell over 1% in the early trade on the NYSE. The stock has risen over 23% in the past year and over 13% in the year so far.

 

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top